Latest news
High-Frequency Chest-Wall Oscillation Devices Market Outlook Signals Expansion To $3.77 Billion Through 2030 - EIN NewsEIN News · Mon, 10 Aug 2026 16:33:00 GMTZydus launches REVAHALE™, India’s first once-daily nebulised long-acting muscarinic antagonist for COPD - BioSpectrum IndiaBioSpectrum India · Mon, 10 Aug 2026 14:35:44 GMTZydus Launches India’s First Once-Daily Nebulised LAMA For COPD - BW Healthcare WorldBW Healthcare World · Mon, 10 Aug 2026 14:21:42 GMTZydus Lifesciences gains after launching once-daily nebulised COPD treatment - Business StandardBusiness Standard · Mon, 10 Aug 2026 12:34:06 GMTKnox Community Hospital to host free COPD Doc Talk in Mount Vernon on Aug. 27 - Your Ohio NewsYour Ohio News · Sat, 08 Aug 2026 18:49:00 GMTExpedition secures $115 million to tackle COPD inflammation - Longevity.TechnologyLongevity.Technology · Thu, 06 Aug 2026 15:34:58 GMTExpedition Therapeutics Secures $115M Series B for COPD Therapy - DealroomDealroom · Wed, 05 Aug 2026 16:57:15 GMTUCLA study compares two COPD treatments to guide patient care - UCLA HealthUCLA Health · Wed, 05 Aug 2026 16:27:32 GMT